Back
Middlefield US Equity Dividend ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
91
MUSA.TO
Middlefield US Equity Dividend ETF
Last Price:
22.52
Seasonality Move:
0.2%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Buy
91
Middlefield US Equity Dividend ETF (MUSA.TO)
is a Buy
Is Middlefield US Equity Dividend ETF a Buy, Sell or Hold?
- The current Middlefield US Equity Dividend ETF [MUSA.TO] share price is $22.52. The Score for MUSA.TO is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
- MUSA.TO is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MUSA.TO Stock Price Chart
What is Middlefield US Equity Dividend ETF's stock price today?
-
The Middlefield US Equity Dividend ETF share price today is $22.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MUSA.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MUSA.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 76.76 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.73 - 22.35) | Buy |
Bollinger Bands (100): | (19.21 - 21.59) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.32 | Buy |
Relative Strength Index (14 RSI): | 81.62 | Buy |
Chaikin Money Flow: | 315379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 26.46) | Buy |
Bollinger Bands (100): | (7.85 - 19.03) | Buy |
MUSA.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.4 | Buy |
20-day SMA: | 22.12 | Buy |
50-day SMA: | 21.43 | Buy |
200-day SMA: | 19.48 | Buy |
8-day EMA: | 22.4 | Buy |
20-day EMA: | 22.12 | Buy |
50-day EMA: | 21.48 | Buy |
200-day EMA: | 19.54 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.35 | Buy |
20-day SMA: | 22.81 | Buy |
50-day SMA: | 14.24 | Buy |
200-day SMA: | 15.81 | Buy |
8-day EMA: | 27.13 | Buy |
20-day EMA: | 22.88 | Buy |
50-day EMA: | 17.49 | Buy |
200-day EMA: | 15.94 | Buy |
Middlefield US Equity Dividend ETF Earnings Growth & MUSA.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Middlefield US Equity Dividend ETF Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |